3 Keys to This Surging Biotech's Star-Studded Year

Biotech is a sector that can make investors rich like no other, and even the biggest players in the business aren't afraid of jumping out to big gains. Take Gilead Sciences¬† (NASDAQ: GILD  ) , one of biotech's top names that has seen its stock roar to gains of more than 87% year-to-date.

Gilead has long dominated the HIV treatment space, but the company's made big moves this year to set it and its investors up for a great future. From the sturdy rise of new HIV compound Stribild to the approval of a new oral hepatitis-C regimen, Gilead hasn't stopped to slow down ever since January kicked off.

But can Gilead's moves this year make you rich for the long term? In the video below, Fool contributor Dan Carroll takes you through three of Gilead's biggest drivers behind its great year -- and what these mean for the stock's long-term potential.

1 market opportunity that's blown away the experts
Gilead has been a big winner in 2013, but can you unearth the next stock set to explode for huge gains? Opportunities to get wealthy from a single investment don't come around often, but they do exist, and our chief technology officer believes he's found one. In this free report, Jeremy Phillips shares the single company that he believes could transform not only your portfolio, but your entire life. To learn the identity of this stock for free and see why Jeremy is putting more than $100,000 of his own money into it, all you have to do is click here now.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2764012, ~/Articles/ArticleHandler.aspx, 9/27/2016 11:46:28 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 hours ago Sponsored by:
DOW 18,228.30 133.47 0.74%
S&P 500 2,159.93 13.83 0.64%
NASD 5,305.71 48.22 0.92%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 4:00 PM
GILD $79.25 Down -1.37 -1.70%
Gilead Sciences CAPS Rating: *****
ABBV $64.57 Up +0.50 +0.78%
AbbVie CAPS Rating: ****
GSK $43.32 Up +0.36 +0.84%
GlaxoSmithKline CAPS Rating: ***
PFE $33.83 Up +0.19 +0.56%
Pfizer CAPS Rating: ****